1. Home
  2. AKBA vs SVC Comparison

AKBA vs SVC Comparison

Compare AKBA & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.40

Market Cap

375.0M

Sector

Health Care

ML Signal

HOLD

SVC

Service Properties Trust

HOLD

Current Price

$1.54

Market Cap

349.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
SVC
Founded
2007
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
375.0M
349.6M
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
AKBA
SVC
Price
$1.40
$1.54
Analyst Decision
Strong Buy
Hold
Analyst Count
4
3
Target Price
$5.25
$2.50
AVG Volume (30 Days)
2.2M
18.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
2.61%
EPS Growth
93.94
26.95
EPS
N/A
N/A
Revenue
N/A
$1,814,838,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$1.13
52 Week High
$4.08
$3.08

Technical Indicators

Market Signals
Indicator
AKBA
SVC
Relative Strength Index (RSI) 49.33 47.47
Support Level $1.30 $1.13
Resistance Level $1.56 $2.42
Average True Range (ATR) 0.08 0.10
MACD -0.00 0.05
Stochastic Oscillator 33.90 81.11

Price Performance

Historical Comparison
AKBA
SVC

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About SVC Service Properties Trust

Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its segments hotel investment unit, and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza, Hyatt Place, and others.

Share on Social Networks: